Who’s watching the drug price watchmen? Are RSV vaccines too expensive? And is it finally time for Novavax to shine?We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Bob Herman joins us to explain his year-long investigation into some brazen conflicts of interest in the world of […]